Stine R Søndergaard1, Poul Henning Madsen2, Ole Hilberg3, Karina M Jensen4, Karina Olling5, Karina D Steffensen6. 1. Department of Internal Medicine, The Lung Cancer Diagnostic Organization, Lillebaelt Hospital, Vejle, Denmark. Electronic address: stine.rauff.sondergaard@rsyd.dk. 2. Department of Internal Medicine, Lillebaelt Hospital, Kolding, Denmark. 3. Department of Internal Medicine, The Lung Cancer Diagnostic Organization, Lillebaelt Hospital, Vejle, Denmark; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark. 4. Department of Internal Medicine, The Lung Cancer Diagnostic Organization, Lillebaelt Hospital, Vejle, Denmark. 5. Center for Shared Decision Making, Lillebaelt Hospital, Vejle, Denmark. 6. Department of Oncology, Lillebaelt Hospital, Vejle, Denmark; Center for Shared Decision Making, Lillebaelt Hospital, Vejle, Denmark; Institute of Regional Health Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
Abstract
OBJECTIVE: The objective of this study was to describe the impact on patient-reported outcomes of introducing Shared Decision Making (SDM) and a Patient Decision Aid (PtDA) in the initial process of lung cancer diagnostics. METHODS: We conducted a prospective cohort study, where a control cohort was consulted according to usual clinical practice. After introducing SDM through a PtDA and training of the staff, the SDM cohort was enrolled in the study. All patients completed four questionnaires: the Decisional Conflict Scale (DCS) before and after the consultation, the CollaboRATE scale after the consultation, and the Decision Regret Scale (DRS). RESULTS: Patients exposed to SDM and a PtDA had significantly improved DCS scores after the consultation compared to the control group (a difference of 10.26, p = 0.0128) and significantly lower DRS scores (a difference of 8.98, p = 0.0197). Of the 82 control patients and 52 SDM patients 29% and 54%, respectively, gave the maximum score on the CollaboRATE scale (Pearson's chi2 8.0946, p = 0.004). CONCLUSION: The use of SDM and a PtDA had significant positive impact on patient-reported outcomes. PRACTICE IMPLICATIONS: Our results may encourage the increased uptake of SDM in the initial process of lung cancer diagnostics.
OBJECTIVE: The objective of this study was to describe the impact on patient-reported outcomes of introducing Shared Decision Making (SDM) and a Patient Decision Aid (PtDA) in the initial process of lung cancer diagnostics. METHODS: We conducted a prospective cohort study, where a control cohort was consulted according to usual clinical practice. After introducing SDM through a PtDA and training of the staff, the SDM cohort was enrolled in the study. All patients completed four questionnaires: the Decisional Conflict Scale (DCS) before and after the consultation, the CollaboRATE scale after the consultation, and the Decision Regret Scale (DRS). RESULTS:Patients exposed to SDM and a PtDA had significantly improved DCS scores after the consultation compared to the control group (a difference of 10.26, p = 0.0128) and significantly lower DRS scores (a difference of 8.98, p = 0.0197). Of the 82 control patients and 52 SDM patients 29% and 54%, respectively, gave the maximum score on the CollaboRATE scale (Pearson's chi2 8.0946, p = 0.004). CONCLUSION: The use of SDM and a PtDA had significant positive impact on patient-reported outcomes. PRACTICE IMPLICATIONS: Our results may encourage the increased uptake of SDM in the initial process of lung cancer diagnostics.